Aktieanalys

Carasent: Focus on Investments - Redeye

{newsItem.title}

Redeye Publicerad: 02 Mar 2022 12:33

Redeye updates its estimates for 2022 following the Q4 report, and comments on various subjects, ranging from organic growth, net revenue retention, Medrave, Webdoc X/NO, and political risks in the case.

Länk till analysen i sin helhet: https://www.redeye.se/research/835271/carasent-focus-on-investments?utm_source=finwire&utm_medium=RSS

Nyheter om Carasent

Läses av andra just nu

Om aktien Carasent

Senaste nytt